REIT - Office
Compare Stocks
4 / 10Stock Comparison
CDP vs BXP vs SLG vs DEA
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Office
REIT - Office
REIT - Office
CDP vs BXP vs SLG vs DEA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | REIT - Office | REIT - Office | REIT - Office | REIT - Office |
| Market Cap | $3.61B | $9.43B | $3.22B | $1.08B |
| Revenue (TTM) | $777M | $3.48B | $981M | $344M |
| Net Income (TTM) | $156M | $277M | $-88M | $15M |
| Gross Margin | 31.9% | 60.6% | 58.2% | 49.7% |
| Operating Margin | 30.1% | 42.3% | 42.7% | 24.9% |
| Forward P/E | 23.7x | 34.7x | — | 69.7x |
| Total Debt | $2.81B | $17.36B | $7.91B | $1.68B |
| Cash & Equiv. | $275M | $1.48B | $336M | $23M |
CDP vs BXP vs SLG vs DEA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| COPT Defense Proper… (CDP) | 100 | 127.0 | +27.0% |
| BXP, Inc. (BXP) | 100 | 69.1 | -30.9% |
| SL Green Realty Cor… (SLG) | 100 | 102.4 | +2.4% |
| Easterly Government… (DEA) | 100 | 37.3 | -62.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CDP vs BXP vs SLG vs DEA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CDP carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 1 yrs, beta 0.37, yield 3.8%
- 59.0% 10Y total return vs SLG's -26.2%
- Lower volatility, beta 0.37, current ratio 1.64x
- Better valuation composite
BXP is the clearest fit if your priority is defensive.
- Beta 0.96, yield 6.8%, current ratio 2.28x
SLG is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 42.0%, EPS growth -21.2%, 3Y rev CAGR 5.2%
- 42.0% FFO/revenue growth vs CDP's 1.4%
DEA is the clearest fit if your priority is momentum.
- +25.0% vs SLG's -13.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 42.0% FFO/revenue growth vs CDP's 1.4% | |
| Value | Better valuation composite | |
| Quality / Margins | 20.1% margin vs SLG's -9.0% | |
| Stability / Safety | Beta 0.37 vs SLG's 1.20, lower leverage | |
| Dividends | 3.8% yield, 1-year raise streak, vs DEA's 9.0%, (1 stock pays no dividend) | |
| Momentum (1Y) | +25.0% vs SLG's -13.3% | |
| Efficiency (ROA) | 3.5% ROA vs SLG's -0.8%, ROIC 4.3% vs 1.1% |
CDP vs BXP vs SLG vs DEA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CDP vs BXP vs SLG vs DEA — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CDP leads in 2 of 6 categories
BXP leads 0 • SLG leads 0 • DEA leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — BXP and SLG each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BXP is the larger business by revenue, generating $3.5B annually — 10.1x DEA's $344M. CDP is the more profitable business, keeping 20.1% of every revenue dollar as net income compared to SLG's -9.0%. On growth, SLG holds the edge at +9.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $777M | $3.5B | $981M | $344M |
| EBITDAEarnings before interest/tax | $399M | $2.4B | $678M | $203M |
| Net IncomeAfter-tax profit | $156M | $277M | -$88M | $15M |
| Free Cash FlowCash after capex | $215M | $690M | $28M | $262M |
| Gross MarginGross profit ÷ Revenue | +31.9% | +60.6% | +58.2% | +49.7% |
| Operating MarginEBIT ÷ Revenue | +30.1% | +42.3% | +42.7% | +24.9% |
| Net MarginNet income ÷ Revenue | +20.1% | +8.0% | -9.0% | +4.3% |
| FCF MarginFCF ÷ Revenue | +27.7% | +19.8% | +2.9% | +76.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.8% | +2.2% | +9.2% | +10.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +9.7% | +2.1% | -13.2% | -55.4% |
Valuation Metrics
Evenly matched — BXP and SLG each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 23.7x trailing earnings, CDP trades at a 70% valuation discount to DEA's 80.3x P/E. On an enterprise value basis, BXP's 8.9x EV/EBITDA is more attractive than SLG's 26.3x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $3.6B | $9.4B | $3.2B | $1.1B |
| Enterprise ValueMkt cap + debt − cash | $6.1B | $25.3B | $10.8B | $2.7B |
| Trailing P/EPrice ÷ TTM EPS | 23.74x | 34.17x | -28.48x | 80.31x |
| Forward P/EPrice ÷ next-FY EPS est. | 23.67x | 34.66x | — | 69.70x |
| PEG RatioP/E ÷ EPS growth rate | 2.63x | — | — | — |
| EV / EBITDAEnterprise value multiple | 15.67x | 8.89x | 26.34x | 13.85x |
| Price / SalesMarket cap ÷ Revenue | 4.72x | 2.71x | 3.21x | 3.21x |
| Price / BookPrice ÷ Book value/share | 2.27x | 1.23x | 0.73x | 0.77x |
| Price / FCFMarket cap ÷ FCF | 14.22x | 13.68x | — | 4.16x |
Profitability & Efficiency
Evenly matched — CDP and BXP and DEA each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
CDP delivers a 9.9% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-2 for SLG. DEA carries lower financial leverage with a 1.23x debt-to-equity ratio, signaling a more conservative balance sheet compared to BXP's 2.26x. On the Piotroski fundamental quality scale (0–9), BXP scores 6/9 vs SLG's 2/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +9.9% | +3.6% | -2.0% | +1.1% |
| ROA (TTM)Return on assets | +3.5% | +1.1% | -0.8% | +0.4% |
| ROICReturn on invested capital | +4.3% | +6.1% | +1.1% | +2.1% |
| ROCEReturn on capital employed | +5.6% | +7.8% | +1.5% | +3.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 2 | 4 |
| Debt / EquityFinancial leverage | 1.77x | 2.26x | 1.82x | 1.23x |
| Net DebtTotal debt minus cash | $2.5B | $15.9B | $7.6B | $1.7B |
| Cash & Equiv.Liquid assets | $275M | $1.5B | $336M | $23M |
| Total DebtShort + long-term debt | $2.8B | $17.4B | $7.9B | $1.7B |
| Interest CoverageEBIT ÷ Interest expense | 2.80x | 1.59x | — | 1.18x |
Total Returns (Dividends Reinvested)
CDP leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CDP five years ago would be worth $13,417 today (with dividends reinvested), compared to $6,297 for DEA. Over the past 12 months, DEA leads with a +25.0% total return vs SLG's -13.3%. The 3-year compound annual growth rate (CAGR) favors SLG at 34.8% vs DEA's -5.7% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +16.9% | -11.3% | -2.3% | +13.5% |
| 1-Year ReturnPast 12 months | +24.2% | -2.4% | -13.3% | +25.0% |
| 3-Year ReturnCumulative with dividends | +46.4% | +38.2% | +144.9% | -16.2% |
| 5-Year ReturnCumulative with dividends | +34.2% | -27.7% | -15.3% | -37.0% |
| 10-Year ReturnCumulative with dividends | +59.0% | -27.8% | -26.2% | -8.7% |
| CAGR (3Y)Annualised 3-year return | +13.5% | +11.4% | +34.8% | -5.7% |
Risk & Volatility
CDP leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CDP is the less volatile stock with a 0.37 beta — it tends to amplify market swings less than SLG's 1.20 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CDP currently trades 95.6% from its 52-week high vs SLG's 67.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.38x | 0.97x | 1.21x | 0.49x |
| 52-Week HighHighest price in past year | $33.29 | $79.33 | $66.91 | $24.94 |
| 52-Week LowLowest price in past year | $26.37 | $49.72 | $34.77 | $19.82 |
| % of 52W HighCurrent price vs 52-week peak | +95.6% | +75.0% | +67.7% | +93.4% |
| RSI (14)Momentum oscillator 0–100 | 51.2 | 63.7 | 63.8 | 54.0 |
| Avg Volume (50D)Average daily shares traded | 898K | 2.4M | 1.3M | 381K |
Analyst Outlook
Evenly matched — CDP and DEA each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CDP as "Buy", BXP as "Buy", SLG as "Hold", DEA as "Hold". Consensus price targets imply 21.3% upside for BXP (target: $72) vs -29.5% for DEA (target: $16). For income investors, DEA offers the higher dividend yield at 9.01% vs CDP's 3.79%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $36.00 | $72.10 | $50.46 | $16.41 |
| # AnalystsCovering analysts | 21 | 42 | 31 | 8 |
| Dividend YieldAnnual dividend ÷ price | +3.8% | +6.8% | — | +9.0% |
| Dividend StreakConsecutive years of raises | 1 | 0 | 0 | 0 |
| Dividend / ShareAnnual DPS | $1.21 | $4.05 | — | $2.10 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% |
CDP leads in 2 of 6 categories — strongest in Total Returns and Risk & Volatility. 4 categories are tied.
CDP vs BXP vs SLG vs DEA: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CDP or BXP or SLG or DEA a better buy right now?
For growth investors, SL Green Realty Corp.
(SLG) is the stronger pick with 42. 0% revenue growth year-over-year, versus 1. 4% for COPT Defense Properties (CDP). COPT Defense Properties (CDP) offers the better valuation at 23. 7x trailing P/E (23. 7x forward), making it the more compelling value choice. Analysts rate COPT Defense Properties (CDP) a "Buy" — based on 21 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CDP or BXP or SLG or DEA?
On trailing P/E, COPT Defense Properties (CDP) is the cheapest at 23.
7x versus Easterly Government Properties, Inc. at 80. 3x. On forward P/E, COPT Defense Properties is actually cheaper at 23. 7x.
03Which is the better long-term investment — CDP or BXP or SLG or DEA?
Over the past 5 years, COPT Defense Properties (CDP) delivered a total return of +34.
2%, compared to -37. 0% for Easterly Government Properties, Inc. (DEA). Over 10 years, the gap is even starker: CDP returned +58. 6% versus BXP's -27. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CDP or BXP or SLG or DEA?
By beta (market sensitivity over 5 years), COPT Defense Properties (CDP) is the lower-risk stock at 0.
38β versus SL Green Realty Corp. 's 1. 21β — meaning SLG is approximately 219% more volatile than CDP relative to the S&P 500. On balance sheet safety, Easterly Government Properties, Inc. (DEA) carries a lower debt/equity ratio of 123% versus 2% for BXP, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CDP or BXP or SLG or DEA?
By revenue growth (latest reported year), SL Green Realty Corp.
(SLG) is pulling ahead at 42. 0% versus 1. 4% for COPT Defense Properties (CDP). On earnings-per-share growth, the picture is similar: BXP, Inc. grew EPS 1833% year-over-year, compared to -21. 2% for SL Green Realty Corp.. Over a 3-year CAGR, SLG leads at 5. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CDP or BXP or SLG or DEA?
COPT Defense Properties (CDP) is the more profitable company, earning 19.
9% net margin versus -8. 8% for SL Green Realty Corp. — meaning it keeps 19. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BXP leads at 55. 7% versus 15. 4% for SLG. At the gross margin level — before operating expenses — BXP leads at 60. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CDP or BXP or SLG or DEA more undervalued right now?
On forward earnings alone, COPT Defense Properties (CDP) trades at 23.
7x forward P/E versus 69. 7x for Easterly Government Properties, Inc. — 46. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BXP: 21. 3% to $72. 10.
08Which pays a better dividend — CDP or BXP or SLG or DEA?
In this comparison, DEA (9.
0% yield), BXP (6. 8% yield), CDP (3. 8% yield) pay a dividend. SLG does not pay a meaningful dividend and should not be held primarily for income.
09Is CDP or BXP or SLG or DEA better for a retirement portfolio?
For long-horizon retirement investors, COPT Defense Properties (CDP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
38), 3. 8% yield). Both have compounded well over 10 years (CDP: +58. 6%, SLG: -25. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CDP and BXP and SLG and DEA?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CDP is a small-cap income-oriented stock; BXP is a small-cap income-oriented stock; SLG is a small-cap high-growth stock; DEA is a small-cap income-oriented stock. CDP, BXP, DEA pay a dividend while SLG does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.